top of page
Patient on Scale

Medically Assisted Weight Loss

01

Initial Consult & Labs

02

Treatment Initiation 

03

Meal Guide

04

Weigh Ins & Follow Ups

Semaglutide

Semaglutide is a glucagon-like peptide-1 receptor (GLP-1) agonist, which helps your pancreas release insulin to decrease blood sugar levels which promotes weight loss. This is done by activating a blood-sugar regulating protein found within the beta cells of your pancreas. It delays stomach emptying leading to a feeling of fullness & satisfaction, and slows intestinal motility. Studies1 have shown that using a GLP-1 once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.1 Participates are showing real results with an average of 12-15lbs loss per month!

​

In a GLP-1 weight loss trial2 that included almost 2000 adults with BMIs of 30 and greater, more than half of the participants lost 15% of their body weight. Most of the participants lost at least 10% of their body weight. The participants were not diabetic indicating GLP-1's are beneficial for weight loss in non-diabetic persons. Also, the participants taking GLP-1s showed improvements in blood pressure, blood sugar, and heart disease risk.

​

References:

1. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

2. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183

Tirzepatide

Tirzepatide is also a a glucagon-like peptide receptor antogonist which basically improves glycemic control in the pancreas. This unique medication mimics two hormones naturally found in the body: GLP-1 and GIP. Tirzepatide also delays gastric empyting which aids in suppressing your appetite.

​

Study's have shown more significant weight loss with Tirzepatide and milder side effects as compared to Semaglutide. Using tirzepatide resulted in a weight loss of 17.8% compared with 12.4% for semaglutide.

Vaccine

Monthly Program

  • Initial consultation with NP

  • Review labs & goals

  • Start weekly dose administration

  • Dietary plan

  • Weekly weigh-ins/follow-up

  • 15% off Slim Goodie or Goat Athlete IV drip

Semaglutide

$450.00/month

Tirzepatide 

Starts at $600/month
Kitchen Scale

Administration

  • Our MAWL program involves an once-weekly injectable prescription medication used for adults with a diagnosis of obesity (BMI >30) or overweight (BMI >27 with weight related chronic conditions), needing help losing weight and keeping it off. 

  • It is given subcutaneously in your abdomen once weekly via tiny needle (similar to insulin injection) 

  • First month, our NP will administer injections. If comfortable the following months you may self-administer at home. 

bottom of page